Matthew Porteus
Plus aucun poste en cours
Fortune : 11 M $ au 31/03/2024
Profil
Matthew Porteus is the founder of CRISPR Therapeutics AG, which was founded in 2013.
He is also the founder of Graphite Bio, Inc., which was founded in 2017.
Dr. Porteus's current job is as a Professor at Stanford University and as an Associate Professor at Stanford School of Medicine since 2010.
His former job was as an Assistant Professor at The University of Texas Southwestern Medical Center from 2003 to 2010.
Dr. Porteus's education includes an undergraduate degree from Harvard University and a doctorate from Stanford University.
Dr. Porteus is also the founder of Kamau Therapeutics, Inc...
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
1,97% | 01/02/2024 | 504 075 ( 1,97% ) | 11 M $ | 31/03/2024 |
Postes actifs de Matthew Porteus
| Sociétés | Poste | Début |
|---|---|---|
| Stanford School of Medicine | Corporate Officer/Principal | 01/10/2010 |
| Stanford University | Corporate Officer/Principal | - |
Anciens postes connus de Matthew Porteus
| Sociétés | Poste | Fin |
|---|---|---|
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | 01/08/2010 |
| LENZ THERAPEUTICS, INC. | Founder | - |
| CRISPR THERAPEUTICS AG | Founder | - |
Formation de Matthew Porteus
| Harvard University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
